Investing in a Longevity Revolution: Sam Altman’s $180 Million Gamble

Sam Altman has invested $180,000,000 into a company that is trying to delay the death of its customers.
Can anti-aging discoveries add 10 years of healthy life to the human lifespan? OpenAI’s CEO is willing to pay for the research.

Source:
https://www.technologyreview.com/2023/03/08/1069523/sam-altman-investment-180-million-retro-biosciences-longevity-death

Leave a Reply

Your email address will not be published. Required fields are marked *